Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 108

Results For "2022"

1413 News Found

Ministry of Health and Family Welfare (MoHFW) organises Health Mela
Public Health | April 18, 2022

Ministry of Health and Family Welfare (MoHFW) organises Health Mela

These melas serve as platforms to attract thousands of people to avail quality healthcare services along with essential medicines and diagnostic services


PM to inaugurate WHO Global Centre for Traditional Medicine at Jamanagar on April 19
Public Health | April 18, 2022

PM to inaugurate WHO Global Centre for Traditional Medicine at Jamanagar on April 19

The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research


Evexia Lifecare's Vadodara API facility starts operations
News | April 17, 2022

Evexia Lifecare's Vadodara API facility starts operations

The company also plans to expand the facility


Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells
Biotech | April 13, 2022

Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells

Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production


Novel Covid-19 vaccine may protect the immunocompromised
Biotech | April 13, 2022

Novel Covid-19 vaccine may protect the immunocompromised

The peptide-based vaccine induces a t cell-dependent response


Jorge Gomez joins Moderna as Chief Financial Officer
People | April 12, 2022

Jorge Gomez joins Moderna as Chief Financial Officer

Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019


Cambrex completes large-scale US API expansion
Biotech | April 12, 2022

Cambrex completes large-scale US API expansion

The expansion positions Cambrex with the largest and most advanced API facility in the United States


New very-high-sensitivity rapid antigen test kits hit Australian market
News | April 11, 2022

New very-high-sensitivity rapid antigen test kits hit Australian market

New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia


Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule
Biotech | April 11, 2022

Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule

GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology


Lonza signs manufacturing deal with Asher Biotherapeutics
Biotech | April 11, 2022

Lonza signs manufacturing deal with Asher Biotherapeutics

Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein